mallinckrodt investor relations | Stock & Investor Info

Keyword	CPC	PCC	Volume	Score	Length of keyword
mallinckrodt investor relations	0.96	0.9	252	82	31
mallinckrodt	0.59	0.8	2695	79	12
investor	0.22	0.6	6625	98	8
relations	1.15	0.3	7862	79	9

Keyword	CPC	PCC	Volume	Score
mallinckrodt investor relations	1.04	0.2	4049	54
mallinckrodt plc investor relations	0.45	0.3	7874	82
mallinckrodt plc share price	1.14	0.7	5910	12
mallinckrodt plc stock price	1.04	0.3	4086	92
mallinckrodt plc news today	1.41	0.6	1387	96
mallinckrodt public limited company stock	0.11	0.2	3896	88
who owns mallinckrodt pharmaceuticals	1.54	0.2	1254	73
mallinckrodt pharmaceuticals phone number	1.35	0.4	4740	55
mallinckrodt stock ticker trading	0.32	0.7	1298	49
mallinckrodt stock yahoo finance	0.95	0.3	5204	6
mallinckrodt pharmaceuticals in the news	0.9	0.6	6623	70
mallinckrodt pharmaceuticals parent company	1.92	0.2	9505	78

Search Results related to mallinckrodt investor relations on Search Engine

Stock & Investor Info | Mallinckrodt Pharmaceuticals
mallinckrodt.com

https://mallinckrodt.com/investors

WEBAug 11, 2022 · Looking for Mallinckrodt Pharmaceuticals investor information? Visit the site to see current stock prices, annual reports, presentations and more.

DA: 84 PA: 42 MOZ Rank: 55

Investor Overview | Mallinckrodt
mallinckrodt.com

https://ir.mallinckrodt.com/

WEBApr 12, 2024 · 26 Mar '24. Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance. Exceeds High End of Guidance Range on Net Sales and Adjusted EBITDA for Fiscal Year Received U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application for Acthar ® Gel …

DA: 69 PA: 24 MOZ Rank: 87

Annual Reports | Mallinckrodt
mallinckrodt.com

https://ir.mallinckrodt.com/annual-reports

WEBInvestor Relations. Annual Reports. Annual Reports; Quarterly & Other Reports; Calendar of Events. Upcoming Events; Past Events; Corporate Governance; Historical Data on Acquired Companies; Information Request; Presentation Documents. Current Year Presentations; Archived Presentations; SEC Filings; Supplemental Financial Information ...

DA: 95 PA: 22 MOZ Rank: 91

Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial
mallinckrodt.com

https://ir.mallinckrodt.com/news-releases/news-release-details/mallinckrodt-plc-reports-fourth-quarter-and-fiscal-2022

WEBFeb 28, 2023 · Further information regarding non-GAAP financial measures can be found on the Investor Relations page of the Company's website. Predecessor and Successor Periods. Mallinckrodt's financial results for the year-to-date period ending December 30, 2022 include Successor and Predecessor periods.

DA: 36 PA: 86 MOZ Rank: 2

Mallinckrodt plc Reports Third Quarter 2022 Financial Results and
mallinckrodt.com

https://ir.mallinckrodt.com/news-releases/news-release-details/mallinckrodt-plc-reports-third-quarter-2022-financial-results

WEBFurther information regarding non-GAAP financial measures can be found on the Investor Relations page of the Company's website. Predecessor and Successor Periods. Mallinckrodt's financial results for the year-to-date period ending September 30, 2022 include Successor and Predecessor periods.

DA: 29 PA: 35 MOZ Rank: 51

Mallinckrodt plc Reports Second Quarter 2022 Financial Results …
mallinckrodt.com

https://ir.mallinckrodt.com/news-releases/news-release-details/mallinckrodt-plc-reports-second-quarter-2022-financial-results

WEBDUBLIN, Aug. 11, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) (" Mallinckrodt " or the "Company"), a global specialty pharmaceutical company, today reported results for the second quarter ended July 1, 2022, 1 …

DA: 93 PA: 12 MOZ Rank: 56

Mallinckrodt plc (in Examinership) Reports Third Quarter 2023 …
mallinckrodt.com

https://ir.mallinckrodt.com/news-releases/news-release-details/mallinckrodt-plc-examinership-reports-third-quarter-2023

WEBDUBLIN, Nov. 7, 2023 /PRNewswire/ -- Mallinckrodt plc (in examinership) (OTCMKTS: MNKTQ) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported its financial results for the third quarter ended September 29, 2023.

DA: 54 PA: 53 MOZ Rank: 79

Presentation Documents | Mallinckrodt Pharmaceuticals
mallinckrodt.com

https://www2.mallinckrodt.com/investors/presentation-documents

WEBContact Investor Relations . [email protected]. Daniel J. Speciale Global Corporate Controller & Chief Investor Relations Officer. Derek Belz Vice President, Investor Relations

DA: 52 PA: 25 MOZ Rank: 16

Mallinckrodt Announces 2024 Extracorporeal Immunomodulation …
mallinckrodt.com

https://ir.mallinckrodt.com/news-releases/news-release-details/mallinckrodt-announces-2024-extracorporeal-immunomodulation

WEB6 days ago · DUBLIN, April 14, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmacy company, today announced that submissions for its 2024 Extracorporeal Immunomodulation Award (EIA) ... Vice President, Investor Relations 314-654-3950 [email protected]. Mallinckrodt, the "M" brand mark and the Mallinckrodt …

DA: 47 PA: 82 MOZ Rank: 14

Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 …
yahoo.com

https://finance.yahoo.com/news/mallinckrodt-plc-reports-fourth-quarter-200100712.html

WEBMar 26, 2024 · Story continues. Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported its financial results for the fourth quarter and fiscal year ended...

DA: 66 PA: 33 MOZ Rank: 30